FDA — Food and Drug Administration logo
FDA — Food and Drug Administration

Minor Use Minor Species Development of Drugs

Funds the safety and effectiveness testing costs of getting a designated new animal drug through FDA approval.

Drug companies rarely bother developing a new drug for a rare animal disease or an uncommon species, because the market is too small to cover the cost of the safety and effectiveness testing FDA approval requires.

This is FDA's Center for Veterinary Medicine (CVM) reimbursing the cost of that testing for animal drugs designated under the Minor Use Minor Species (MUMS) programme — drugs for minor …

Research Project (R01) grants reimbursing the safety and effectiveness testing costs of new animal drugs designated for minor uses in major species or for minor species, for applicants who already hold an open Investigational New Animal Drug file and a MUMS designation with FDA's Center for Veterinary Medicine.

CycleiHow often this grant runs - e.g. annually, on a rolling basis, or a one-off call.Multiple per year
Next deadlineiThe next date applications are due. Rolling means you can apply any time.29 Jan 2027
Decision timeiTypical time from the deadline to the funder's decision.-
Project durationiHow long the funded work is expected to run.-
Award typeiThe form of funding - grant, equity, loan, tax credit, etc.Grant
Match fundingiThe share of project costs you must cover yourself. 0% = fully funded.-
Funding pooliThe total budget available across all awards in this round.$250K

Sign up free to see the funding breakdown

Sign up free to see the industries in scope

Sign up free to see the full eligibility

Sign up free to see how to apply

Sign up free to see how they score you

Sign up free to see the timeline

Sign up free to see where teams trip up

Guides for this application

All guides →
FDA — Food and Drug Administration logo
Open

Laboratory Flexible Funding Model (LFFM)

🇺🇸FDA · United States

Funds state, territorial and tribal food- and animal-testing laboratories to run sample testing and lab capacity work for FDA's food safety system.

$1.5MJan'28
FDA — Food and Drug Administration logo
Open

Reissue of RFA-FD-22-001 - Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases

FDA · United States

Funds natural history studies that track how a rare disease unfolds over time, to close data gaps blocking new treatments for it.

Biotech
$600KFeb'28
FDA — Food and Drug Administration logo
Open

Animal and Veterinary Innovation Centers

🇺🇸FDA · United States

Funds academic institutions to become long-term FDA partners researching bird flu, animal genomics and unmet veterinary needs.

BiotechAgritech
$1.3MMay'28
FDA — Food and Drug Administration logo
Open

Reissue of RFA-FD-23-001- Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases

FDA · United States

Funds clinical trials testing whether a product works and is safe for a rare disease, aimed at a new indication or a labeling change.

Biotech
$900KMay'28
FDA — Food and Drug Administration logo
Open

Vet-LIRN Capacity-Building Project and Equipment Grants

🇺🇸FDA · United States

Funds equipment and capacity-building projects for veterinary diagnostic labs fighting animal-food hazards and drug resistance.

Agritech
$225K – $2.5MSep'28
FDA — Food and Drug Administration logo
Between cycles

Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases

FDA · United States

Funds foreign and domestic entities running rare-disease clinical trials through FDA orphan products research grants.

BiotechMedtech
$900K